Adenocarcinoma of the Rectum Completed Phase 1 Trials for AUY922 (DB11881)

IndicationStatusPhase
DBCOND0028688 (Adenocarcinoma of the Rectum)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01294826Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal CancerTreatment